The present study investigated the expression of the CCCs, KCC2 and NKCC1 in primary mouse hippocampal neurons and mouse hippocampal tissue, and the effect of bumetanide, an NKCC1 inhibitor, on KCC2 and NKCC1 expression in an in vitro AD mouse model. The gene discussed is SLC12A2; the disease is Alzheimer disease.